Abstract: Four new labdane-type diterpenoids: hedychicoronarin (1), peroxycoronarin D (2), 7β-hydroxycalcaratarin A (3), and (E)-7β-hydroxy-6-oxo-labda-8(17),12-diene-15,16-dial (4), have been isolated from the rhizomes of Hedychium coronarium, together with 13 known compounds (5-17). The structures of these new compounds were determined through spectroscopic and MS analyses. Compounds 3, 5, 6, and 10 exhibited inhibition (IC 50 values ≤4.52 μg/mL) of superoxide anion generation by human neutrophils in response to formyl-L-methionyl-L-leucyl-L-phenylalanine/cytochalasin B (fMLP/CB). Compounds 3-6, 10, and 11 inhibited fMLP/CB-induced elastase release with IC 50 values ≤6.17 μg/mL.
Introduction
Hedychium coronarium Koenig (Zingiberaceae) is a perennial herb distributed in India, Southeast Asian countries, southern China, Japan, and Taiwan [1] . H. coronarium, popularly called "White Butterfly Flower" or "Butterfly Ginger", is used as a folk medicine for treatment of headache, contusion, inflammation, insomnia, stomach disorders, and sharp pain due to rheumatism in China [2, 3] .
Labdane-type diterpenes [3] [4] [5] [6] [7] [8] [9] , farnesane-type sesquiterpenes [2] , and their derivatives were isolated from this plant in previous studies. Many of these compounds were found to exhibit antiallergic [2] , cytotoxic [3, 4, 9] , anti-inflammatory [6, 7] , and hepatoprotective [8] activities. Granule proteases (e.g., elastase, cathepsin G, and proteinase-3) and reactive oxygen species (ROS) (e.g., superoxide anion (O 2
•− ) and hydrogen peroxide) produced by human neutrophils are involved in the pathogenesis of a variety of inflammatory diseases.
In our studies on the anti-inflammatory constituents of Formosan plants, many species have been screened for in vitro inhibitory activity on neutrophil pro-inflammatory responses, and H. coronarium has been found to be an active species. The MeOH extract of the rhizomes of H. coronarium showed potent inhibitory effects on superoxide anion generation and elastase release by human neutrophils in response to formyl-L-methionyl-L-leucyl-L-phenylalanine/cytochalasin B (fMLP/CB). Figure 1 illustrates the structures of four new labdane-type diterpenoids: hedychicoronarin (1), peroxycoronarin D (2), 7β-hydroxycalcaratarin A (3), and (E)-7β-hydroxy-6-oxo-labda-8(17),12-diene-15,16-dial (4) . Thirteen known compounds (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , have been isolated and identified from the rhizomes of H. coronarium and their structures are depicted in Figure 2 . This paper describes the structural elucidation of the compounds numbered 1 through 4, and the inhibitory activities of all isolates on superoxide generation and elastase release by neutrophils. C-NMR data of 1 was similar to those of coronarin D methyl ether (8) [10] , except that the 2-methoxy-2-oxoethyl group [δ H 2.64 (1H, dd, J = 16.0, 7.2 Hz, H-1'a), 2.85 (1H, dd, J = 16.0, 6.4 Hz, H-1'b), and 3.72 (3H, s, OMe-2'); δ C 40.6 (C-1'), 52.0 (OMe), and 170.0 (C-2')] at C-15 of 1 replaced the 15-methoxy group [δ H 3.52/3.53 (3H, s, OMe-15); δ C 56.54 (OMe-15)] of 8. This was supported by (i) HMBC correlation observed between H-1' (δ 2.64, 2.85) and C-14 (δ 31.3), C-15 (δ 73.0), and C-2' (δ 170.0); and (ii) HMBC correlation observed between OMe-2' (δ 3.72) and C-2' (δ 170.0). The relative stereochemistry of 1 was elucidated on the basis of NOESY experiments (Figure 3 ). The NOESY cross-peaks between H-5/H-7α, H-5/H-9, H-5/H 3 -18, H 2 -11/H 3 -20, and H 3 -19/H 3 -20 suggested that H-5, H-7α, H-9, and H 3 -18 are α-oriented, and H 3 -19 and H 3 -20 are β-oriented. The occurrence of epimers of labdane diterpenes at C-15 position has been previously reported [3, [10] [11] [12] . These labdane diterpenes with C-15 substituent were usually isolated as C-15 epimeric mixtures, which could not be separated. The presence of duplicated resonances of 13 C-NMR signals of 1 at C-7 (δ 37.74/37.76), C-8 (δ 148.03/148.06), C-9 (δ 56.12/56.15), C-10 (δ 39.40/39.41), C-12 (δ 143.16/143.18), and C-17 (δ 107.36/107.43) as in the cases of coronarin D [10] and coronarin D methyl ether [10] suggested that it was isolated as a C-15 epimeric mixture. On the basis of the evidence above, the structure of 1 was elucidated as methyl 2-((E)-5-oxo-4-(2-((1S,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)ethylidene)tetrahydrofu-ran-2-yl)acetate, named hedychicoronarin. This was further confirmed by [14] , coronarin A (6) [4] , coronarin D (7) [4, 10] , coronarin D methyl ether (8) [15] , coronarin D ethyl ether (9) [16] , and (E)-labda-8(17),12-diene-15,16-dial (10) [4, 5] , five steroids, ergosta-4,6,8(14),22-tetraen-3-one (11) [17] , a mixture of β-sitostenone (12) and β-stigmasta-4,22-dien-3-one (13) [18] , and a mixture of 6β-hydroxystigmast-4-en-3-one (14) and 6β-hydroxystigmasta-4,22-dien-3-one (15) [19] , and a mixture of stearic acid (16) and palmitic acid (17) [20] .
Human neutrophils are known to play crucial roles in host defence against microorganisms and in pathogenesis of different diseases, such as rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), asthma, and ischemia-reperfusion injury [21] [22] [23] [24] . In response to diverse stimuli, activated neutrophils secrete a series of cytotoxins, such as the superoxide anion radical (O 2
•− ), a precursor to other reactive oxygen species (ROS), granule proteases, bioactive lipids, and neutrophil elastase, a major contributor to destruction of tissue in chronic inflammatory disease [21, 25, 26] . Suppression of the extensive or inappropriate activation of neutrophils by drugs has been proposed as a method to ameliorate inflammatory diseases. The effects on neutrophil pro-inflammatory responses of compounds isolated from the rhizomes of H. coronarium were evaluated by suppressing fMet-Leu-Phe/cytochalasin B (fMLP/CB)-induced superoxide anion (O 2
•− ) generation and elastase release by human neutrophils. The inhibitory activity data on neutrophil pro-inflammatory responses are summarized in Table 1 . LY294002, a phosphatidylinositol-3-kinase inhibitor, was used as a positive control for superoxide anion generation and elastase release. Diphenyleneiodonium, an NADPH oxidase inhibitor, was used as a positive control for superoxide anion generation. From the results of our biological tests, the following conclusions can be drawn: 2, and 6-9) , coronarin A (6) (with a hydroxy group at C-7 and a furan-3-yl group at C-12) exhibited more effective inhibition than its analogues, 1, 2, and 7-9 (without any substituent at C-7 and with a 2-oxo-5-substituted-tetrahydrofuran-3-yl group at C-12) against fMLP-induced O 2
•− generation and elastase release. (g) Calcaratarin A (5) displayed the most effective among the isolates, with IC 50 values of 2.25 ± 0.42 and 2.36 ± 0.41 μg/mL, respectively, against fMLP-induced O 2
•− generation and elastase release. Our study suggests H. coronarium and its isolates (especially 3, 5, 6, and 10) could be further developed as potential candidates for the treatment or prevention of various inflammatory diseases. Thus, the detailed mechanism of action of these compounds appears worthy of further investigation. 
Experimental Section

General Experimental Procedures
Melting points were determined on a Yanaco micro-melting point apparatus and were uncorrected. Optical rotations were measured using a Jasco DIP-370 polarimeter in CHCl 3 . Ultraviolet (UV) spectra were obtained on a Jasco UV-240 spectrophotometer. Infrared (IR) spectra (neat or KBr) were recorded on a Perkin Elmer 2000 FT-IR spectrometer. Nuclear magnetic resonance (NMR) spectra, including correlation spectroscopy (COSY), nuclear Overhauser effect spectrometry (NOESY), heteronuclear multiple-bond correlation (HMBC), and heteronuclear single-quantum coherence (HSQC) experiments, were acquired using a Varian Unity 400 or a Varian Unity Plus-600 spectrometer operating at 400 or 600 MHz ( 1 H) and 100 or 150 MHz ( 13 C), respectively, with chemical shifts given in ppm (δ) using tetramethylsilane (TMS) as an internal standard. Electrospray ionisation (ESI) and high-resolution electrospray ionization (HRESI)-mass spectra were recorded on a Bruker APEX II or a VG Platform Electrospray ESI/MS mass spectrometer. Silica gel (70-230, 230-400 mesh, Merck) was used for column chromatography (CC). Silica gel 60 F-254 (Merck, Darmstadt, Germany) was used for thin-layer chromatography (TLC) and preparative thin-layer chromatography (PTLC).
Plant Material
The rhizomes of H. coronarium were collected from Taitung District Agricultural Research and Extension Station, Taitung County, Taiwan, in June 2009 and identified by J. F. Chen. A voucher specimen (Chen 3011) was deposited in the Department of Pharmacy, Tajen University, Pingtung, Taiwan.
Extraction and Isolation
The dried rhizomes (6.2 kg) of H. coronarium were extracted three times with MeOH (30 L each) for 3 days. The MeOH extracts were concentrated under reduced pressure at 35 °C, and the residue (638 g) was partitioned between n-hexane and H 2 O (1:1). The n-hexane layer was concentrated to give a residue (fraction A, 112 g). The water layer was further extracted with n-BuOH, and the n-BuOH-soluble part (fraction B, 245 g) and the water-solubles (fraction C, 258 g) were separated. . Fraction A5-6 (510 mg) was purified by MPLC (silica gel column, 230-400 mesh, n-hexane/acetone, 5:1) to afford 10 fractions (each 160 mL, A5-6-1-A5-6-10). Fraction A5-6-5 (85 mg) was purified by preparative TLC (silica gel, CHCl 3 /EtOAc, 50:1) to afford 1 (4.2 mg) (R f = 0.58). Fraction A5-7 (87 mg) was purified by preparative TLC (silica gel, n-hexane/acetone, 10:1) to obtain 5 (2.5 mg) (R f = 0.57). Fraction A5-10 (162 mg) was purified by preparative TLC (silica gel, CHCl 3 /acetone, 50:1) to afford a mixture of 16 and 17 (5.7 mg) (R f = 0.50). Fraction A6 (9.5 g) was chromatographed further on silica gel (230-400 mesh, 430 g) eluting with n-hexane/acetone (8:1) to give 14 fractions (each 900 mL, A6-1-A6-14). Fraction A6-5 (132 mg) was purified by preparative TLC (silica gel, n-hexane/acetone, 6:1) to afford 3 (2.8 mg) (R f = 0.53). Fraction A6-6 (245 mg) was purified by preparative TLC (silica gel, n-hexane/EtOAc, 5:1) to obtain 6 (43 mg) (R f = 0.62) and 8 (57 mg) (R f = 0.45). Fraction A6-10 (175 mg) was purified by preparative TLC (silica gel, CH 2 Cl 2 /MeOH, 15:1) to yield a mixture of 14 and 15 (5.3 mg) (R f = 0.67). Fraction A7 (10.8 g) was chromatographed further on silica gel (230-400 mesh, 485 g) eluting with n-hexane/acetone (5:1) to give 12 fractions (each 850 mL, A7-1-A7-12). Fraction A7-4 (178 mg) was purified by preparative TLC (silica gel, n-hexane/acetone, 5:1) to afford 2 (2.6 mg) (R f = 0.71) and 7 (3.4 mg) (R f = 0.64). Fraction A7-5 (165 mg) was purified by preparative TLC (silica gel, CHCl 3 /MeOH, 15:1) to yield 9 (4.6 mg) (R f = 0.62). Fraction A7-6 (138 mg) was purified by preparative TLC (silica gel, CH 2 Cl 2 /MeOH, 12:1) to obtain 4 (3.1 mg) (R f = 0.59). 3H, s, H-20), 0.81 (3H, s, H-19), 0.88 (3H, s, H-18 
Biological Assay
The effect of the isolated compounds on neutrophil pro-inflammatory response was evaluated by monitoring the inhibition of superoxide anion generation and elastase release in fMLP/CB-activated human neutrophils in a concentration-dependent manner. The purity of the tested compounds was >98% as identified by NMR and MS. LY294002 (purity >99%, Sigma, St. Louis, MO, USA) was used as a positive control.
Preparation of Human Neutrophils
Human neutrophils from venous blood of healthy, adult volunteers (20-28 years old) were isolated using a standard method of dextran sedimentation prior to centrifugation in a Ficoll Hypaque gradient and hypotonic lysis of erythrocytes [27] . Purified neutrophils containing >98% viable cells, as determined by the trypan blue exclusion method [28] , were re-suspended in a calcium (Ca 2+ )-free HBSS buffer at pH 7.4 and were maintained at 4 °C prior to use.
Measurement of Superoxide Anion Generation
The assay for measurement of superoxide anion generation was based on the SOD-inhibitable reduction of ferricytochrome c [29, 30] . In brief, after supplementation with 0.5 mg/mL ferricytochrome c and 1 mM Ca 2+ , neutrophils (6 × 10 5 /mL) were equilibrated at 37 °C for 2 min and incubated with different concentrations (10-0.01 μg/mL) of compounds or DMSO (as control) for 5 min. Cells were incubated with cytochalasin B (1 μg/mL) for 3 min prior to the activation with 100 nM formyl-L-methionyl-L-leucyl-L-phenylalanine for 10 min. Changes in absorbance with the reduction of ferricytochrome c at 550 nm were continuously monitored in a double-beam, six-cell positioner spectrophotometer with constant stirring (Hitachi U-3010, Tokyo, Japan). Calculations were based on differences in the reactions with and without SOD (100 U/mL) divided by the extinction coefficient for the reduction of ferricytochrome c (ε = 21.1/mM/10 mm).
Measurement of Elastase Release
Degranulation of azurophilic granules was determined by measuring elastase release as described previously [30] . Experiments were performed using MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide as the elastase substrate. Briefly, after supplementation with MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide (100 μM), neutrophils (6 × 10 5 /mL) were equilibrated at 37 °C for 2 min and incubated with compounds for 5 min. Cells were stimulated with fMLP (100 nM)/CB (0.5 μg/mL), and changes in absorbance at 405 nm were monitored continuously in order to assay elastase release. The results were expressed as the percent of elastase release in the fMLP/CB-activated, drug-free control system.
Statistical Analysis
Results are expressed as the mean ± SEM, and comparisons were made using Student's t-test. A probability of 0.05 or less was considered significant. The software SigmaPlot was used for the statistical analysis.
Conclusions
Seventeen compounds, including four new labdane-type diterpenoids 1-4, were isolated from the rhizome of H. coronarium. The structures of these compounds were established on the basis of spectroscopic data. Reactive oxygen species (ROS) [e.g., superoxide anion (O 2 generation and elastase release. The above isolated compounds might support the traditional use of H. coronarium for the treatment of inflammatory processes. Our study suggests H. coronarium and its isolates (especially 3, 5, 6, and 10) could be further developed as potential candidates for the treatment or prevention of various inflammatory diseases.
